Y Song, Z Wu, P Zhao - Frontiers in Pharmacology, 2022 - frontiersin.org
Metformin is a widely accepted first-line hypoglycemic agent in current clinical practice, and
it has been applied to the clinic for more than 60 years. Recently, researchers have …